Dis-Chem Pharmacies Limited

JSE:DCP Rapporto sulle azioni

Cap. di mercato: R31.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Dis-Chem Pharmacies Gestione

Gestione criteri di controllo 4/4

Dis-Chem Pharmacies' Il CEO è Rui Morais, nominato in Jul2023, e ha un mandato di 1.08 anni. la retribuzione annua totale è ZAR 16.70M, composta da 74.8% di stipendio e 25.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.99% delle azioni della società, per un valore di ZAR 312.61M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.1 anni e 3.6 anni.

Informazioni chiave

Rui Morais

Amministratore delegato

R16.7m

Compenso totale

Percentuale dello stipendio del CEO74.8%
Mandato del CEO1.1yrs
Proprietà del CEO1.0%
Durata media del management2.1yrs
Durata media del Consiglio di amministrazione3.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Aug 21
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Jun 06
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Rui Morais rispetto agli utili di Dis-Chem Pharmacies?
DataCompenso totaleStipendioGuadagni aziendali
Feb 29 2024R17mR12m

R984m

Nov 30 2023n/an/a

R942m

Aug 31 2023n/an/a

R899m

May 31 2023n/an/a

R949m

Feb 28 2023R18mR12m

R1b

Nov 30 2022n/an/a

R1b

Aug 31 2022n/an/a

R1b

May 31 2022n/an/a

R946m

Feb 28 2022R14mR11m

R853m

Nov 30 2021n/an/a

R815m

Aug 31 2021n/an/a

R776m

May 31 2021n/an/a

R722m

Feb 28 2021R6mR6m

R669m

Nov 30 2020n/an/a

R655m

Aug 31 2020n/an/a

R641m

May 31 2020n/an/a

R620m

Feb 29 2020R6mR6m

R598m

Nov 30 2019n/an/a

R573m

Aug 31 2019n/an/a

R549m

May 31 2019n/an/a

R634m

Feb 28 2019R5mR5m

R719m

Nov 30 2018n/an/a

R718m

Aug 31 2018n/an/a

R718m

May 31 2018n/an/a

R701m

Feb 28 2018R7mR5m

R684m

Compensazione vs Mercato: La retribuzione totale di Rui ($USD 943.85K ) è circa la media per le aziende di dimensioni simili nel mercato ZA ($USD 1.13M ).

Compensazione vs guadagni: La retribuzione di Rui è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Rui Morais (40 yo)

1.1yrs

Mandato

R16,702,000

Compensazione

Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Rui Morais
CEO & Executive Director1.1yrsR16.70m0.99%
ZAR 312.6m
J. Pope
CFO & Executive Director1.1yrsR5.19mNessun dato
Ivan Saltzman
Executive Director1.2yrsR18.45mNessun dato
Lynette Saltzman
Managing Director19.3yrsR14.97mNessun dato
Saul Saltzman
Executive Director2.1yrsR7.56m0.79%
ZAR 248.0m
Stanley Richard Goetsch
Executive Director2.1yrsR7.58m4.65%
ZAR 1.5b
Christopher Williams
Prescribed Officerno dataR7.81mNessun dato
Craig Fairweather
Commercial Directorno dataR15.38m0.0045%
ZAR 1.4m
C. Swanepoel
Prescribed Officerno dataR4.61m0.0012%
ZAR 369.3k
T. Ponter
Prescribed Officerno dataR5.11mNessun dato
Caryn Barker
Human Resources Directorno dataNessun datoNessun dato
Nikki Lumley
Company Secretary3.4yrsNessun datoNessun dato

2.1yrs

Durata media

67yo

Età media

Gestione esperta: Il team dirigenziale di DCP è considerato esperto (durata media dell'incarico 2.1 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Rui Morais
CEO & Executive Director12yrsR16.70m0.99%
ZAR 312.6m
J. Pope
CFO & Executive Director1.1yrsR5.19mNessun dato
Ivan Saltzman
Executive Director19.3yrsR18.45mNessun dato
Saul Saltzman
Executive Director2.1yrsR7.56m0.79%
ZAR 248.0m
Stanley Richard Goetsch
Executive Director2.1yrsR7.58m4.65%
ZAR 1.5b
Laurence Nestadt
Independent Non-Executive Chairman7.8yrsR3.34m0.058%
ZAR 18.4m
Johannes Mthimunye
Independent Non-Executive Director7.8yrsR967.00k0.0095%
ZAR 3.0m
Anuschka Coovadia
Independent Non-Executive Director7.8yrsR691.00k0.019%
ZAR 6.0m
Alupheli Sithebe
Independent Non-Executive Director3.6yrsR750.00kNessun dato
Katlego K. Kobue
Non-Independent Non Executive Director2.8yrsR560.00kNessun dato
Happy Masondo
Independent Non-Executive Director2.1yrsR788.00kNessun dato

3.6yrs

Durata media

53.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DCP sono considerati esperti (durata media dell'incarico 3.6 anni).